We are live on ! Find out more
TIL icon

Instil Bio
TIL

30 hedge funds and large institutions have $30M invested in Instil Bio in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

57.55% more ownership

Funds ownership: 3.08% → 60.64% (+58%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

13% less capital invested

Capital invested by funds: $34.3M → $30M (-$4.3M)

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

48% less funds holding

Funds holding: 58 → 30 (-28)

93% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 30

Holders
30
Holders Change
-28
Holders Change %
-48.28%
% of All Funds
0.44%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
9
Reduced
16
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$559K
2
Renaissance Technologies
Renaissance Technologies
New York
+$444K
3
Citadel Advisors
Citadel Advisors
Florida
+$188K
4
AFM
Anson Funds Management
Texas
+$125K
5
Squarepoint
Squarepoint
New York
+$99K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$2.01M
2
WSL
Western Standard LLC
California
-$769K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$371K
4
Millennium Management
Millennium Management
New York
-$285K
5
BlackRock
BlackRock
New York
-$219K
Name Holding Trade Value Shares
Change 		Change in
Stake
CVV
1
Curative Ventures V
Texas
$14.5M – – –
VC
2
Vivo Capital
California
$4.76M +$7 +1 +0%
CI
3
CPMG Inc
Texas
$3.13M – – –
CCC
4
Cable Car Capital
California
$1.97M +$1.87M +258,097 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$991K -$25.5K -3,529 -3%
NCM
6
Nantahala Capital Management
Connecticut
$970K +$559K +77,292 +155%
Renaissance Technologies
7
Renaissance Technologies
New York
$866K +$444K +61,343 +117%
Marshall Wace
8
Marshall Wace
United Kingdom
$462K – – –
Two Sigma Investments
9
Two Sigma Investments
New York
$387K -$17.1K -2,362 -4%
Millennium Management
10
Millennium Management
New York
$379K -$285K -39,379 -44%
BlackRock
11
BlackRock
New York
$287K -$219K -30,282 -45%
Two Sigma Advisers
12
Two Sigma Advisers
New York
$280K -$2.35K -325 -0.9%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$240K -$12.1K -1,676 -5%
Citadel Advisors
14
Citadel Advisors
Florida
$216K +$188K +25,966 +1,113%
Squarepoint
15
Squarepoint
New York
$212K +$99K +13,689 +97%
AFM
16
Anson Funds Management
Texas
$132K +$125K +17,344 New
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$106K -$81K -11,199 -44%
State Street
18
State Street
Massachusetts
$95.9K -$7 -1 -0%
Morgan Stanley
19
Morgan Stanley
New York
$77.1K +$61K +8,440 +504%
TRCT
20
Tower Research Capital (TRC)
New York
$2.45K -$7.1K -981 -75%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$1K +$1.12K +155 +15,500%
UBS Group
22
UBS Group
Switzerland
$922 +$723 +100 +476%
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$868 -$7 -1 -0.9%
LC
24
Lindbrook Capital
California
$518 -$7 -1 -1%
Wells Fargo
25
Wells Fargo
California
$236 +$22 +3 +11%
1
2 3

TIL Hedge Fund Activity: Q4 2023 in Review

30 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q4 2023, worth a combined $30M — down 13% from $34.3M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of TIL and 2 opened new positions — a net loss of 28 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Nantahala Capital Management, adding an estimated $559K. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $2.01M sold.

  • 30 institutional investors held Instil Bio (TIL) as of Q4 2023, down from 58 in Q3 2023.
  • Funds reported $30M of Instil Bio stock for Q4 2023, down 13% quarter-over-quarter.
  • 2 funds opened new Instil Bio positions in Q4 2023 and 30 closed out, a net change of -28 holders.
  • The largest Instil Bio buyer in Q4 2023 was Nantahala Capital Management, an estimated $559K added.
  • The largest Instil Bio seller in Q4 2023 was Baker Bros. Advisors, an estimated $2.01M sold.

Based on aggregated 13F filings for Q4 2023.